Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ragweed MATAMPL and Pollinex-R in Ragweed Allergy
NCT00110786Phase 2Completed
- Sponsor
- Allergy Therapeutics PLC
- Start
- May 2005
- Modality
- Allergy Immunotherapy
- Countries
- 1
01
Overview
A Phase 2 trial of Pollinex Quattro Ragweed in seasonal allergic rhinitis (SAR), sponsored by Allergy Therapeutics PLC. Started May 2005; status: completed.
02
Drugs
Pollinex Quattro Ragweed
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT00110786.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00110786.